secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001104659-26-034601
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics closes $5.0M offering of common stock and warrants
-----------------------------------------------------------------------

- 20M shares + 20M warrants sold at $0.25/unit; gross proceeds ~$5.0M, net ~$4.0M.
- Warrants exercisable immediately at $0.25, expire in 5 years; includes 4.99%/9.99% beneficial ownership limitation.
- H.C. Wainwright placement agent, receiving 7% cash fee and 1.4M warrants at $0.3125.
- Company agreed to one-year ban on variable rate transactions and lock-up agreements.
- Offering closed March 25, 2026; net proceeds ~$4.0M for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926034601/0001104659-26-034601-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926034601/tm269822d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-034601

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer